We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clears Illumina’s ‘Next-Gen Sequencing,’ Cystic Fibrosis Dx
FDA Clears Illumina’s ‘Next-Gen Sequencing,’ Cystic Fibrosis Dx
San Diego-based Illumina will begin filling orders for its high-throughput gene sequencing tests and two other diagnostics by the end of the year, following FDA 510(k) clearance of all four devices.